The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

Ege University87 enrolled

Overview

The aim of this study is to investigate whether the albumin value and the ratios of biochemical markers; hemoglobin, albumin, lymphocyte and platelet (HALP score) and lymphocyte-C-reactive protein ratio (LCR) can predict the survival and recurrence of the disease in patients with pancreatic adenocarcinoma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pancreatic Neoplasms Pancreas Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Whipple operation and total pancreatectomy due to pathologically confirmed pancreatic adenocarcinoma Exclusion Criteria: * Patients with other malignant tumors (choledochal tumor, papilla tumor and duodenal tumor)

Outcomes

Primary Outcomes

Disease-Free Survival Times

Time frame: 4 Years

HALP Score

Hemoglobin x Albumin x Lymphocyte / Platelet

Time frame: 4 Years

Overall Survival Time

Time frame: 4 Years

LCR Score

Lymphocyte / CRP

Time frame: 4 Years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.